Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations
Published in the NEJM this week was a study intended to conclusively determine whether corticosteroids are an effective adjunctive therapy in severe sepsis. Although …
Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations
Published in the NEJM this week was a study intended to conclusively determine whether corticosteroids are an effective adjunctive therapy in severe sepsis. Although …
Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. These posts focus on evidenced based answers to clinical questions related to patients seen by our students …
In this series, we try to cut through some of the media hype and summarize the health care proposals put forward by the leading candidates for President.
Commentary by Aaron Lord MD, …
Commentary by Judith Brenner MD, Associate Program Director, NYU Internal Medicine Residency Program
This week’s Annals of Internal Medicine focused on angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB). Two …
Commentary by David Steckman MD, PGY-2 and William Slater MD, Associate Professor of Medicine, Division of Cardiology
Case: A 42 year-old man presents to clinic for routine follow-up. He is found …
Welcome to the first post of our newest series. In this series, we’ll try to cut through some of the media hype and summarize the health care proposals put forward by …
Is there evidence to support the use of Lantus® (human insulin analog glargine) administered Q12h in Type 1 Diabetes?
Commentary by Kathy Lee, Pharmacy Resident
The goal of diabetes management is to reduce …
Commentary by Rosemary Adamson MD, PGY-2
Medical error, the most formidable of topics, was under discussion at ground rounds this past week. Dr. Tom Delbanco visited us from Boston to show his movie …